Crinetics Pharmaceuticals (CRNX)

• Market cap: $4.01B
• 1 day: 0.05%
• 5 days: -0.95%
• 1 month: 2.04%
• 3 months: 45.45%
• 6 months: 26.39%
• Year to date: -17.5%
• 1 year: -26.43%
• 5 years: 215.74%
• 10 years: 73.52%
• Sector: Healthcare
• Industry: Biotechnology

About: Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

Employees: 437